US 11951100
Formulations of RBP4 inhibitors and methods of use
granted A61KA61K31/437A61K31/4545
Quick answer
US patent 11951100 (Formulations of RBP4 inhibitors and methods of use) held by Belite Bio, Inc expires Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Belite Bio, Inc
- Grant date
- Tue Apr 09 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/437, A61K31/4545, A61K9/10, A61K9/146